-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Recommendation of "Buy" by Brokerages
Source: Buzz FX / 03 Jan 2025 02:46:14 America/New_York
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Recommendation of "Buy" by Brokerages Written by MarketBeat January 3, 2025 Share Link copied to clipboard. Crinetics Pharmaceuticals, Inc.
Read more...